Review of extreme breast radiation schedules in Brazil
Part of Injuries & trauma clinical trials.
This study looks back at medical records to understand outcomes when breast cancer patients get a very short course of radiation after surgery. It may help doctors learn whether this “extreme hypofractionation” schedule is safe and effective for more patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman age 18 or older
- Have a breast cancer diagnosis of any type
- Have surgery first, then receive this specific radiation schedule (5 sessions of 5.2Gy)
- Have treatment starting from December 2019 or later
- Have your clinical and treatment details available in your medical records
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial compares two schedules of radiation after breast surgery in people with high-risk, node-positive breast cancer. The goal is to see whether giving radiation in 1 week or 2 weeks works well and is safe after standard treatments.
This trial studies giving whole-breast radiation in a shorter, more concentrated way after breast-conserving surgery. It aims to see if this “ultra-short” schedule is effective and safe for people with early breast cancer.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This study looks at giving radiation after breast surgery using a very “hypo-fractionated” schedule, meaning fewer visits with higher dose per visit. It aims to see if this approach is safe and effective for certain breast cancer and DCIS patients after complete tumor removal.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
Hear when a new Radiotherapy Side Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.